Do analysts prefer TACO or AMN?

AMN Healthcare Services has a consensus price target of $36.00, suggesting a potential downside of 1.95%. Given AMN Healthcare Services' stronger consensus rating and higher probable upside, analysts plainly believe AMN Healthcare Services is more favorable than Berto Acquisition. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Berto Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 AMN Healthcare Services 0 Sell rating(s) 4 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.50

Which has better valuation and earnings, TACO or AMN?

Berto Acquisition has higher earnings, but lower revenue than AMN Healthcare Services. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Berto Acquisition N/A N/A N/A N/A N/A AMN Healthcare Services $2.73B 0.52 -$95.70M $2.68 13.70

Does the media prefer TACO or AMN?

In the previous week, AMN Healthcare Services had 2 more articles in the media than Berto Acquisition. MarketBeat recorded 3 mentions for AMN Healthcare Services and 1 mentions for Berto Acquisition. Berto Acquisition's average media sentiment score of 1.90 beat AMN Healthcare Services' score of 0.83 indicating that Berto Acquisition is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Berto Acquisition 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive AMN Healthcare Services 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend TACO or OMDA?

Omada Health has a consensus target price of $26.67, suggesting a potential upside of 30.91%. Given Omada Health's stronger consensus rating and higher possible upside, analysts plainly believe Omada Health is more favorable than Berto Acquisition. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Berto Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Omada Health 1 Sell rating(s) 2 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.71

Which has better earnings and valuation, TACO or OMDA?

Berto Acquisition has higher earnings, but lower revenue than Omada Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Berto Acquisition N/A N/A N/A N/A N/A Omada Health $260.21M 4.79 -$12.78M $0.05 407.40

Does the media favor TACO or OMDA?

In the previous week, Omada Health had 3 more articles in the media than Berto Acquisition. MarketBeat recorded 4 mentions for Omada Health and 1 mentions for Berto Acquisition. Berto Acquisition's average media sentiment score of 1.90 beat Omada Health's score of 0.82 indicating that Berto Acquisition is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Berto Acquisition 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Omada Health 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate TACO or OPK?

OPKO Health has a consensus target price of $1.55, indicating a potential downside of 0.64%. Given OPKO Health's stronger consensus rating and higher possible upside, analysts clearly believe OPKO Health is more favorable than Berto Acquisition. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Berto Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 OPKO Health 1 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.33

Which has preferable earnings & valuation, TACO or OPK?

Berto Acquisition has higher earnings, but lower revenue than OPKO Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Berto Acquisition N/A N/A N/A N/A N/A OPKO Health $606.90M 1.92 -$225.68M -$0.09 N/A

Does the media prefer TACO or OPK?

In the previous week, OPKO Health had 4 more articles in the media than Berto Acquisition. MarketBeat recorded 5 mentions for OPKO Health and 1 mentions for Berto Acquisition. Berto Acquisition's average media sentiment score of 1.90 beat OPKO Health's score of 0.80 indicating that Berto Acquisition is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Berto Acquisition 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive OPKO Health 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer CSTL or TACO?

Castle Biosciences currently has a consensus price target of $42.00, indicating a potential upside of 18.11%. Given Castle Biosciences' stronger consensus rating and higher possible upside, equities analysts clearly believe Castle Biosciences is more favorable than Berto Acquisition. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Castle Biosciences 1 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.80 Berto Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings and valuation, CSTL or TACO?

Berto Acquisition has lower revenue, but higher earnings than Castle Biosciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Castle Biosciences $344.23M 3.16 -$24.16M -$0.66 N/A Berto Acquisition N/A N/A N/A N/A N/A

Does the media refer more to CSTL or TACO?

In the previous week, Castle Biosciences had 10 more articles in the media than Berto Acquisition. MarketBeat recorded 11 mentions for Castle Biosciences and 1 mentions for Berto Acquisition. Berto Acquisition's average media sentiment score of 1.90 beat Castle Biosciences' score of 0.43 indicating that Berto Acquisition is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Castle Biosciences 4 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Berto Acquisition 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Do analysts prefer TACO or LMRI?

Lumexa Imaging has a consensus price target of $16.00, suggesting a potential upside of 55.04%. Given Lumexa Imaging's stronger consensus rating and higher possible upside, analysts clearly believe Lumexa Imaging is more favorable than Berto Acquisition. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Berto Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Lumexa Imaging 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.00

Which has better earnings and valuation, TACO or LMRI?

Berto Acquisition has higher earnings, but lower revenue than Lumexa Imaging. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Berto Acquisition N/A N/A N/A N/A N/A Lumexa Imaging $267.73M 3.70 -$47.10M -$0.49 N/A

Is TACO or LMRI more profitable?

Company Net Margins Return on Equity Return on Assets Berto Acquisition N/A N/A N/A Lumexa Imaging N/A N/A N/A

Does the media refer more to TACO or LMRI?

In the previous week, Lumexa Imaging had 3 more articles in the media than Berto Acquisition. MarketBeat recorded 4 mentions for Lumexa Imaging and 1 mentions for Berto Acquisition. Berto Acquisition's average media sentiment score of 1.90 beat Lumexa Imaging's score of 0.67 indicating that Berto Acquisition is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Berto Acquisition 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Lumexa Imaging 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Berto Acquisition (TACO) Competitors

$10.46 -0.01 (-0.10%)

Closing price 10/2/2026 03:59 PM Eastern

Extended Trading

$10.46 +0.00 (+0.05%)

As of 10/2/2026 04:10 PM Eastern

Compare

TACO vs. AMN, OMDA, OPK, CSTL, and LMRI

Should you buy Berto Acquisition stock or one of its competitors? Berto Acquisition's main competitors and comparable companies include AMN Healthcare Services (AMN), Omada Health (OMDA), OPKO Health (OPK), Castle Biosciences (CSTL), and Lumexa Imaging (LMRI). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Berto Acquisition compare to AMN Healthcare Services?

Berto Acquisition (NASDAQ:TACO) and AMN Healthcare Services (NYSE:AMN) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, earnings, analyst recommendations, dividends, institutional ownership, valuation and risk.

Berto Acquisition has a beta of 0.08, meaning that its stock price is 92% less volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.4, meaning that its stock price is 60% less volatile than the broader market.

Berto Acquisition has higher earnings, but lower revenue than AMN Healthcare Services.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Berto Acquisition	N/A	N/A	N/A	N/A	N/A
AMN Healthcare Services	$2.73B	0.52	-$95.70M	$2.68	13.70

AMN Healthcare Services has a net margin of 3.06% compared to Berto Acquisition's net margin of 0.00%. AMN Healthcare Services' return on equity of 19.92% beat Berto Acquisition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Berto Acquisition	N/A	N/A	N/A
AMN Healthcare Services	3.06%	19.92%	5.93%

99.2% of AMN Healthcare Services shares are held by institutional investors. 13.2% of Berto Acquisition shares are held by insiders. Comparatively, 1.1% of AMN Healthcare Services shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

AMN Healthcare Services has a consensus price target of $36.00, suggesting a potential downside of 1.95%. Given AMN Healthcare Services' stronger consensus rating and higher probable upside, analysts plainly believe AMN Healthcare Services is more favorable than Berto Acquisition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Berto Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
AMN Healthcare Services	0 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

In the previous week, AMN Healthcare Services had 2 more articles in the media than Berto Acquisition. MarketBeat recorded 3 mentions for AMN Healthcare Services and 1 mentions for Berto Acquisition. Berto Acquisition's average media sentiment score of 1.90 beat AMN Healthcare Services' score of 0.83 indicating that Berto Acquisition is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Berto Acquisition	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
AMN Healthcare Services	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

AMN Healthcare Services beats Berto Acquisition on 10 of the 12 factors compared between the two stocks.

How does Berto Acquisition compare to Omada Health?

Berto Acquisition (NASDAQ:TACO) and Omada Health (NASDAQ:OMDA) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, media sentiment, profitability, dividends, valuation, institutional ownership and earnings.

Omada Health has a net margin of 1.39% compared to Berto Acquisition's net margin of 0.00%. Omada Health's return on equity of 2.60% beat Berto Acquisition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Berto Acquisition	N/A	N/A	N/A
Omada Health	1.39%	2.60%	1.98%

Berto Acquisition has higher earnings, but lower revenue than Omada Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Berto Acquisition	N/A	N/A	N/A	N/A	N/A
Omada Health	$260.21M	4.79	-$12.78M	$0.05	407.40

Omada Health has a consensus target price of $26.67, suggesting a potential upside of 30.91%. Given Omada Health's stronger consensus rating and higher possible upside, analysts plainly believe Omada Health is more favorable than Berto Acquisition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Berto Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Omada Health	1 Sell rating(s)	2 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.71

Berto Acquisition has a beta of 0.08, suggesting that its share price is 92% less volatile than the broader market. Comparatively, Omada Health has a beta of 2.03, suggesting that its share price is 103% more volatile than the broader market.

In the previous week, Omada Health had 3 more articles in the media than Berto Acquisition. MarketBeat recorded 4 mentions for Omada Health and 1 mentions for Berto Acquisition. Berto Acquisition's average media sentiment score of 1.90 beat Omada Health's score of 0.82 indicating that Berto Acquisition is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Berto Acquisition	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Omada Health	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Omada Health beats Berto Acquisition on 9 of the 10 factors compared between the two stocks.

How does Berto Acquisition compare to OPKO Health?

Berto Acquisition (NASDAQ:TACO) and OPKO Health (NASDAQ:OPK) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their media sentiment, institutional ownership, valuation, earnings, risk, dividends, profitability and analyst recommendations.

64.6% of OPKO Health shares are owned by institutional investors. 13.2% of Berto Acquisition shares are owned by company insiders. Comparatively, 44.7% of OPKO Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, OPKO Health had 4 more articles in the media than Berto Acquisition. MarketBeat recorded 5 mentions for OPKO Health and 1 mentions for Berto Acquisition. Berto Acquisition's average media sentiment score of 1.90 beat OPKO Health's score of 0.80 indicating that Berto Acquisition is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Berto Acquisition	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
OPKO Health	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

OPKO Health has a consensus target price of $1.55, indicating a potential downside of 0.64%. Given OPKO Health's stronger consensus rating and higher possible upside, analysts clearly believe OPKO Health is more favorable than Berto Acquisition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Berto Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
OPKO Health	1 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.33

Berto Acquisition has a net margin of 0.00% compared to OPKO Health's net margin of -12.40%. Berto Acquisition's return on equity of 0.00% beat OPKO Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Berto Acquisition	N/A	N/A	N/A
OPKO Health	-12.40%	-5.88%	-3.83%

Berto Acquisition has a beta of 0.08, meaning that its share price is 92% less volatile than the broader market. Comparatively, OPKO Health has a beta of 1.51, meaning that its share price is 51% more volatile than the broader market.

Berto Acquisition has higher earnings, but lower revenue than OPKO Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Berto Acquisition	N/A	N/A	N/A	N/A	N/A
OPKO Health	$606.90M	1.92	-$225.68M	-$0.09	N/A

Summary

OPKO Health beats Berto Acquisition on 9 of the 13 factors compared between the two stocks.

How does Berto Acquisition compare to Castle Biosciences?

Castle Biosciences (NASDAQ:CSTL) and Berto Acquisition (NASDAQ:TACO) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation.

Castle Biosciences currently has a consensus price target of $42.00, indicating a potential upside of 18.11%. Given Castle Biosciences' stronger consensus rating and higher possible upside, equities analysts clearly believe Castle Biosciences is more favorable than Berto Acquisition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Castle Biosciences	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.80
Berto Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Castle Biosciences has a beta of 0.94, meaning that its share price is 6% less volatile than the broader market. Comparatively, Berto Acquisition has a beta of 0.08, meaning that its share price is 92% less volatile than the broader market.

Berto Acquisition has a net margin of 0.00% compared to Castle Biosciences' net margin of -5.43%. Berto Acquisition's return on equity of 0.00% beat Castle Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Castle Biosciences	-5.43%	-4.15%	-3.45%
Berto Acquisition	N/A	N/A	N/A

92.6% of Castle Biosciences shares are owned by institutional investors. 6.1% of Castle Biosciences shares are owned by company insiders. Comparatively, 13.2% of Berto Acquisition shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Berto Acquisition has lower revenue, but higher earnings than Castle Biosciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Castle Biosciences	$344.23M	3.16	-$24.16M	-$0.66	N/A
Berto Acquisition	N/A	N/A	N/A	N/A	N/A

In the previous week, Castle Biosciences had 10 more articles in the media than Berto Acquisition. MarketBeat recorded 11 mentions for Castle Biosciences and 1 mentions for Berto Acquisition. Berto Acquisition's average media sentiment score of 1.90 beat Castle Biosciences' score of 0.43 indicating that Berto Acquisition is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Castle Biosciences	4 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Berto Acquisition	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

Castle Biosciences beats Berto Acquisition on 8 of the 13 factors compared between the two stocks.

How does Berto Acquisition compare to Lumexa Imaging?

Berto Acquisition (NASDAQ:TACO) and Lumexa Imaging (NASDAQ:LMRI) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, media sentiment, valuation, institutional ownership, earnings and dividends.

Lumexa Imaging has a consensus price target of $16.00, suggesting a potential upside of 55.04%. Given Lumexa Imaging's stronger consensus rating and higher possible upside, analysts clearly believe Lumexa Imaging is more favorable than Berto Acquisition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Berto Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Lumexa Imaging	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	2 Strong Buy rating(s)	3.00

Berto Acquisition has higher earnings, but lower revenue than Lumexa Imaging.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Berto Acquisition	N/A	N/A	N/A	N/A	N/A
Lumexa Imaging	$267.73M	3.70	-$47.10M	-$0.49	N/A

In the previous week, Lumexa Imaging had 3 more articles in the media than Berto Acquisition. MarketBeat recorded 4 mentions for Lumexa Imaging and 1 mentions for Berto Acquisition. Berto Acquisition's average media sentiment score of 1.90 beat Lumexa Imaging's score of 0.67 indicating that Berto Acquisition is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Berto Acquisition	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Lumexa Imaging	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Net Margins	Return on Equity	Return on Assets
Berto Acquisition	N/A	N/A	N/A
Lumexa Imaging	N/A	N/A	N/A

Summary

Lumexa Imaging beats Berto Acquisition on 6 of the 7 factors compared between the two stocks.

Get Berto Acquisition News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TACO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TACO vs. The Competition

Export

Metric	Berto Acquisition	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$341.26M	$9.59B	$7.14B	$13.17B
Dividend Yield	N/A	2.61%	2.53%	16.78%
P/E Ratio	N/A	34.21	275.68	26.04
Price / Sales	N/A	5.39	662.25	102.14
Price / Cash	N/A	120.59	77.60	51.75
Price / Book	N/A	5.15	10.93	6.31
Net Income	N/A	$315.68M	$3.51B	$362.16M
7 Day Performance	0.10%	-2.59%	-2.00%	-1.66%
1 Month Performance	-0.29%	-3.19%	-6.15%	-4.50%
1 Year Performance	0.48%	7.93%	7.44%	2.06%

Berto Acquisition Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TACO Berto Acquisition	1.4163 of 5 stars	$10.46 -0.1%	N/A	+0.6%	$341.26M	N/A	N/A	7,892	Positive News
AMN AMN Healthcare Services	1.2597 of 5 stars	$33.81 -2.1%	$36.00 +6.5%	+87.8%	$1.34B	$2.73B	12.62	2,664
OMDA Omada Health	3.6632 of 5 stars	$20.69 -3.2%	$26.67 +28.9%	-10.0%	$1.31B	$260.21M	413.80	946	Analyst Downgrade
OPK OPKO Health	1.2028 of 5 stars	$1.70 -1.7%	$1.55 -8.8%	+1.3%	$1.29B	$606.90M	N/A	1,373	News Coverage
CSTL Castle Biosciences	2.3843 of 5 stars	$34.88 +0.1%	$42.00 +20.4%	+60.0%	$1.06B	$357.28M	N/A	1,002	News Coverage Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TACO) was last updated on 10/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Berto Acquisition (TACO) Competitors

TACO vs. AMN, OMDA, OPK, CSTL, and LMRI

How does Berto Acquisition compare to AMN Healthcare Services?

Summary

How does Berto Acquisition compare to Omada Health?

Summary

How does Berto Acquisition compare to OPKO Health?

Summary

How does Berto Acquisition compare to Castle Biosciences?

Summary

How does Berto Acquisition compare to Lumexa Imaging?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TACO vs. The Competition

Berto Acquisition Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Berto Acquisition (TACO) Competitors

TACO vs. AMN, OMDA, OPK, CSTL, and LMRI

How does Berto Acquisition compare to AMN Healthcare Services?

Which has more risk and volatility, TACO or AMN?

Which has better valuation and earnings, TACO or AMN?

Is TACO or AMN more profitable?

Do institutionals and insiders hold more shares of TACO or AMN?

Do analysts prefer TACO or AMN?

Does the media prefer TACO or AMN?

Summary

How does Berto Acquisition compare to Omada Health?

Is TACO or OMDA more profitable?

Which has better earnings and valuation, TACO or OMDA?

Do analysts recommend TACO or OMDA?

Which has more volatility & risk, TACO or OMDA?

Does the media favor TACO or OMDA?

Summary

How does Berto Acquisition compare to OPKO Health?

Do institutionals and insiders have more ownership in TACO or OPK?

Does the media prefer TACO or OPK?

Do analysts rate TACO or OPK?

Is TACO or OPK more profitable?

Which has more risk and volatility, TACO or OPK?

Which has preferable earnings & valuation, TACO or OPK?

Summary

How does Berto Acquisition compare to Castle Biosciences?

Do analysts prefer CSTL or TACO?

Which has more risk and volatility, CSTL or TACO?

Is CSTL or TACO more profitable?

Do institutionals & insiders believe in CSTL or TACO?

Which has higher earnings and valuation, CSTL or TACO?

Does the media refer more to CSTL or TACO?

Summary

How does Berto Acquisition compare to Lumexa Imaging?

Do analysts prefer TACO or LMRI?

Which has better earnings and valuation, TACO or LMRI?

Does the media refer more to TACO or LMRI?

Is TACO or LMRI more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TACO vs. The Competition

Berto Acquisition Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools